MaltSci 麦伴科研

Appearance

Popular Reports / Genomics

This report is written by MaltSci based on the latest literature and research findings

What is the role of telomeres in aging and cancer? ​

Abstract ​

Telomeres are specialized structures at the ends of eukaryotic chromosomes that play a critical role in maintaining genomic integrity and regulating cellular lifespan. They consist of repetitive DNA sequences and associated proteins that protect chromosome ends from degradation and fusion. Each time a cell divides, telomeres shorten, leading to cellular senescence and apoptosis when they reach a critically short length. This progressive telomere shortening is associated with aging and age-related diseases, including cancer. Conversely, cancer cells often reactivate telomerase, an enzyme that elongates telomeres, allowing for unlimited cell division and contributing to tumorigenesis. This review explores the complex relationship between telomeres, aging, and cancer, emphasizing the dual role of telomeres in limiting cellular proliferation and promoting genomic instability. We discuss the implications of telomere length in age-related diseases and the therapeutic potential of targeting telomerase in cancer treatment. Additionally, we highlight future directions in telomere research, including emerging technologies and the potential for personalized medicine strategies aimed at modulating telomere dynamics. Overall, understanding telomere biology is essential for developing novel therapeutic interventions to combat aging and cancer.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Telomere Structure and Function
    • 2.1 Composition and Mechanism of Telomere Protection
    • 2.2 Role of Telomerase in Telomere Maintenance
  • 3 Telomeres and Aging
    • 3.1 Telomere Shortening and Cellular Senescence
    • 3.2 Impact of Telomere Length on Age-Related Diseases
  • 4 Telomeres and Cancer
    • 4.1 Telomere Dysfunction in Tumorigenesis
    • 4.2 Telomerase Reactivation in Cancer Cells
  • 5 Therapeutic Implications
    • 5.1 Targeting Telomerase in Cancer Therapy
    • 5.2 Potential Interventions to Preserve Telomere Length
  • 6 Future Directions in Telomere Research
    • 6.1 Emerging Technologies in Telomere Studies
    • 6.2 The Role of Telomeres in Personalized Medicine
  • 7 Conclusion

1 Introduction ​

Telomeres, the specialized structures at the ends of eukaryotic chromosomes, serve as critical guardians of genomic integrity. Composed of repetitive DNA sequences and associated proteins, telomeres play an essential role in preventing chromosomal degradation during cell division. However, with each replication cycle, telomeres progressively shorten, leading to a phenomenon known as replicative senescence. This gradual loss of telomeric DNA is closely linked to aging and the onset of age-related diseases, including cancer. The intricate relationship between telomeres, aging, and cancer has garnered significant attention in recent years, as it holds profound implications for our understanding of these biological processes and potential therapeutic interventions.

The significance of telomeres in the context of aging and cancer cannot be overstated. Telomere shortening is a hallmark of cellular aging, contributing to the decline in tissue function and regenerative capacity. As individuals age, the cumulative effects of oxidative stress, inflammation, and other environmental factors exacerbate telomere attrition, ultimately leading to cellular senescence and apoptosis [1]. Conversely, in cancer cells, the reactivation of telomerase, the enzyme responsible for elongating telomeres, allows for unlimited cell division, thus circumventing the normal limits imposed by telomere shortening [2]. This dual role of telomeres highlights their pivotal position at the intersection of aging and tumorigenesis, underscoring the need for a comprehensive understanding of their biological functions.

Current research has elucidated various mechanisms through which telomeres influence both aging and cancer. For instance, critically short telomeres can activate DNA damage responses, triggering senescence and apoptosis [3]. This protective mechanism serves to suppress tumorigenesis in younger individuals, but as telomere length diminishes with age, the risk of developing cancer increases [4]. Additionally, telomere dysfunction is implicated in a range of age-related diseases, with studies demonstrating that both excessively short and long telomere lengths can contribute to cancer development [1]. These findings emphasize the importance of maintaining telomere homeostasis as a potential strategy for promoting healthy aging and reducing cancer risk.

The organization of this review will begin with an overview of telomere structure and function, including the composition and mechanisms underlying telomere protection, as well as the role of telomerase in telomere maintenance. Following this, we will explore the relationship between telomeres and aging, discussing how telomere shortening contributes to cellular senescence and the impact of telomere length on age-related diseases. The subsequent section will delve into the role of telomeres in cancer, examining the consequences of telomere dysfunction in tumorigenesis and the mechanisms of telomerase reactivation in cancer cells. We will also address the therapeutic implications of targeting telomerase in cancer therapy and potential interventions aimed at preserving telomere length. Finally, we will highlight future directions in telomere research, including emerging technologies and the potential role of telomeres in personalized medicine.

In summary, the interplay between telomeres, aging, and cancer represents a dynamic field of study with significant implications for understanding fundamental biological processes and developing novel therapeutic strategies. By synthesizing current knowledge and recent advancements in this area, this review aims to provide insights into how telomere biology can inform strategies for combating age-related diseases and cancer, emphasizing the necessity for further investigation in this promising field.

2 Telomere Structure and Function ​

2.1 Composition and Mechanism of Telomere Protection ​

Telomeres are specialized structures located at the ends of linear chromosomes, composed of repetitive DNA sequences and associated proteins. Their primary role is to protect chromosome ends from deterioration and fusion with neighboring chromosomes, thereby maintaining genomic stability. Telomeres achieve this protection through their unique structure, which prevents the activation of DNA damage response pathways that would otherwise lead to cell cycle arrest, senescence, or apoptosis.

The composition of telomeres includes telomeric DNA, which consists of tandem repeats of the nucleotide sequence (TTAGGG in humans), and a variety of proteins that bind to these sequences, forming a protective cap. This cap structure is essential for preserving the integrity of the chromosome during cell division. As somatic cells undergo replication, telomeres shorten progressively due to the end-replication problem, where DNA polymerase cannot fully replicate the terminal ends of linear chromosomes. When telomeres reach a critically short length, they become "uncapped," leading to chromosomal instability and triggering cellular senescence or apoptosis, which is a significant mechanism contributing to aging.

In the context of aging, the gradual shortening of telomeres is associated with a decline in cellular function and an increase in age-related diseases. The loss of telomere length has been implicated in various age-related disorders, including cancer. Notably, telomeres play a dual role in cancer development. While short telomeres can act as a barrier to tumorigenesis by inducing senescence, their dysfunction can lead to chromosomal instability, a hallmark of cancer. As such, cells with critically short telomeres may exhibit genomic instability, providing a substrate for oncogenic mutations and clonal evolution.

Interestingly, in most human cancer cells, telomerase, an enzyme that synthesizes telomeric DNA, is reactivated, allowing these cells to maintain telomere length and bypass the normal limits on cell division. This reactivation of telomerase is a common feature in over 90% of human cancers, facilitating continuous cell proliferation and contributing to the immortalization of cancer cells. Therefore, the regulation of telomere length and telomerase activity is a critical area of research, as it holds potential therapeutic implications for both aging and cancer treatment.

Recent studies have highlighted the importance of telomeres in the interplay between aging and cancer, emphasizing the need for a deeper understanding of telomere biology. The complex dynamics of telomere shortening and telomerase activity underline their significant roles in both aging and the development of cancer, suggesting that strategies aimed at modulating telomere dynamics could have profound implications for promoting healthy aging and developing effective cancer therapies[1][5][6].

2.2 Role of Telomerase in Telomere Maintenance ​

Telomeres, the protective caps at the ends of linear chromosomes, play a critical role in maintaining genomic stability and regulating cellular lifespan. They consist of repetitive DNA sequences and associated proteins that protect chromosome ends from degradation and prevent inappropriate activation of DNA repair pathways. The integrity of telomeres is vital for cellular function, and their length is closely linked to the aging process and the development of cancer.

As cells divide, telomeres gradually shorten due to the inability of DNA polymerases to fully replicate the ends of linear chromosomes, a phenomenon known as the "end replication problem." When telomeres reach a critically short length, they trigger cellular senescence or apoptosis, thereby acting as a barrier to uncontrolled cell proliferation. This mechanism is particularly significant in somatic cells, where telomerase activity is generally absent. Telomerase, a ribonucleoprotein complex that includes the telomerase reverse transcriptase (TERT), is responsible for the elongation and maintenance of telomeres. In most human somatic cells, telomerase is repressed, leading to telomere shortening with each cell division, which contributes to aging and age-related pathologies [7].

In contrast, most cancer cells exhibit reactivation of telomerase, allowing them to maintain telomere length and bypass the growth-limiting effects associated with short telomeres. This reactivation is a hallmark of cancer and enables continuous cell division, contributing to tumorigenesis [8]. The dual role of telomeres and telomerase in aging and cancer highlights a complex relationship: while telomere shortening serves as a protective mechanism against cancer by limiting cellular proliferation, the reactivation of telomerase in cancer cells facilitates tumor growth and progression [1].

Recent studies suggest that both excessively short and long telomere lengths can promote cancer development. Short telomeres may lead to chromosomal instability, a driving factor in tumorigenesis, while long telomeres, often associated with telomerase activation, can provide a proliferative advantage to cancer cells [9]. Moreover, telomere dysfunction has been implicated in various age-related diseases, including cancer, where the balance of telomere length is disrupted [6].

In summary, telomeres serve as critical regulators of cellular aging and cancer. Their length is maintained by telomerase, which is typically inactive in somatic cells but reactivated in most cancer cells, leading to a paradoxical relationship where the same mechanisms that protect against aging can also facilitate cancer development. Understanding the intricate dynamics of telomere biology is essential for developing therapeutic strategies aimed at targeting telomerase in cancer treatment while considering its implications in aging [10].

3 Telomeres and Aging ​

3.1 Telomere Shortening and Cellular Senescence ​

Telomeres, the protective structures at the ends of linear chromosomes, play a pivotal role in the processes of aging and cancer through mechanisms that involve telomere shortening and cellular senescence. As cells divide, telomeres progressively shorten due to the inability of DNA polymerases to fully replicate the ends of linear chromosomes. This shortening serves as a biological clock that limits the number of times a cell can divide, thereby playing a crucial role in cellular aging and the onset of senescence.

In somatic cells, the average telomere length declines with age, which poses a barrier to tumor growth but also contributes to the loss of functional cells over time. When telomeres become critically short, they can no longer adequately protect chromosome ends, leading to the activation of DNA damage response pathways. This can trigger cellular senescence or apoptosis, mechanisms that act as tumor suppressive responses. The likelihood of senescence increases as telomeres shorten, creating a situation where cells with critically short or "uncapped" telomeres accumulate, thereby limiting cellular proliferation and promoting aging [5].

Conversely, in the context of cancer, the erosion of telomeres initially acts as a barrier to tumor development. However, cancer cells often reactivate telomerase, the enzyme responsible for maintaining telomere length, allowing them to bypass this barrier. In fact, approximately 90% of human cancers exhibit reactivation of telomerase, which enables these cells to maintain telomere length and continue dividing indefinitely [2]. The reactivation of telomerase not only supports continuous proliferation but also contributes to genomic instability, a hallmark of cancer progression [7].

Moreover, telomere dysfunction can lead to a state of genomic instability that fosters the accumulation of mutations, further driving oncogenesis. In individuals with short telomeres, the risk of developing certain cancers may paradoxically decrease, as these individuals often have impaired cell proliferation due to senescence [11]. This suggests that while short telomeres are associated with aging and cellular decline, they may also provide a protective effect against the uncontrolled proliferation characteristic of cancer.

In summary, telomeres serve a dual role in aging and cancer. They limit cellular lifespan through progressive shortening, which contributes to aging and cellular senescence. In cancer, however, the ability of cells to reactivate telomerase and maintain telomere length facilitates tumor growth and progression. Understanding the intricate balance between telomere length, cellular senescence, and cancer development is essential for developing therapeutic strategies aimed at both aging and cancer [1][4].

3.2 Impact of Telomere Length on Age-Related Diseases ​

Telomeres, the protective caps at the ends of linear chromosomes, play a crucial role in both aging and cancer, primarily through their influence on cellular senescence and genomic stability. As individuals age, telomeres progressively shorten due to the replication process, which can ultimately lead to cellular senescence or apoptosis when they reach a critically short length. This process is a significant contributor to the aging phenotype and age-related diseases.

Aubert and Lansdorp (2008) highlight that telomeres are essential for maintaining genome stability and that critically short or "uncapped" telomeres trigger apoptosis or cellular senescence in somatic cells. The likelihood of accumulating uncapped telomeres increases as the average telomere length decreases with age. In the context of aging, this decline in telomere length is associated with various disorders, including cancer, pulmonary fibrosis, and aplastic anemia. Specifically, mutations that lead to telomerase deficiencies, resulting in shorter telomeres, are implicated in these age-related pathologies [5].

Conversely, in cancer, the dynamics of telomere length can shift dramatically. While normal somatic cells exhibit telomere shortening as a protective mechanism against tumorigenesis, most cancer cells reactivate telomerase, which allows them to maintain telomere length and evade senescence. This phenomenon is noted by Kim et al. (2002), who emphasize that telomerase reactivation is a hallmark of nearly all human cancers, facilitating continuous cell division and contributing to tumor progression [12].

Moreover, Boccardi and Marano (2025) discuss the dual role of telomeres in aging and cancer, noting that fragile telomeres, characterized by replication stress, may offer insights into the mechanisms linking aging to cancer susceptibility. They propose that the accumulation of fragile telomeres could be a critical factor in this relationship [1].

The implications of telomere length and telomerase activity extend to potential therapeutic strategies aimed at modulating these factors. In cancer treatment, telomerase inhibitors are being explored as a means to target cancer cells specifically, as these cells often exhibit high levels of telomerase activity, unlike normal somatic cells, which typically do not express this enzyme [7].

In summary, telomeres serve as critical regulators of cellular lifespan and genomic integrity, influencing both the aging process and the development of cancer. Their gradual shortening is associated with age-related diseases, while their reactivation in cancer cells enables uncontrolled proliferation. Understanding these dynamics is essential for developing targeted therapies aimed at mitigating the effects of aging and treating cancer.

4 Telomeres and Cancer ​

4.1 Telomere Dysfunction in Tumorigenesis ​

Telomeres, the protective structures at the ends of chromosomes, play a critical role in both aging and cancer. They are composed of repetitive DNA sequences and associated proteins, serving to maintain genomic stability and integrity. As cells divide, telomeres shorten due to the end-replication problem, ultimately leading to cellular senescence or apoptosis when they reach a critically short length. This process is particularly relevant in somatic cells, where telomerase activity is typically absent, resulting in gradual telomere erosion over time (Aubert & Lansdorp, 2008; Lansdorp, 2022).

In the context of aging, telomere shortening is a significant contributor to the decline in cellular function. The accumulation of critically short or "uncapped" telomeres activates DNA damage response pathways, which can lead to apoptosis or senescence, thereby reducing the pool of functional cells. This phenomenon is linked to various age-related diseases, including cancer, where the incidence increases with age (Boccardi & Marano, 2025; Lansdorp, 2022).

Telomere dysfunction is intricately connected to tumorigenesis. In cancer cells, telomerase, an enzyme that can elongate telomeres, is often reactivated, allowing these cells to bypass the normal limits on cell division. This reactivation of telomerase enables cancer cells to maintain their telomere length despite continuous divisions, thereby promoting cellular immortality (Urquidi et al., 1998; Ouellette et al., 2011). Consequently, the presence of dysfunctional telomeres can lead to genomic instability, a hallmark of cancer, as they trigger mutations and chromosomal abnormalities that facilitate tumor progression (Lansdorp, 2022; Deng et al., 2008).

Moreover, the relationship between telomeres and cancer is not merely a function of their length but also involves their structural integrity. Fragile telomeres, which exhibit replication stress and abnormalities, can contribute to the onset of oncogenic changes. The dynamic nature of telomeres necessitates large longitudinal studies to better understand their role in cancer susceptibility and aging, as well as to develop strategies aimed at promoting healthy aging while mitigating cancer risk (Boccardi & Marano, 2025).

In summary, telomeres are crucial in the interplay between aging and cancer. Their gradual shortening is a significant factor in cellular aging, while dysfunction in telomere maintenance mechanisms can lead to genomic instability and cancer development. The dual role of telomerase as both a facilitator of cellular immortality in cancer and a potential target for therapeutic intervention highlights the complexity of telomere biology in the context of human health (Geserick & Blasco, 2006; Armanios, 2022).

4.2 Telomerase Reactivation in Cancer Cells ​

Telomeres, the protective caps at the ends of linear chromosomes, play a pivotal role in the processes of aging and cancer. They are composed of repetitive DNA sequences and associated proteins that are crucial for maintaining genomic stability. As cells divide, telomeres shorten, which eventually leads to replicative senescence and apoptosis when they reach a critical length. This mechanism serves as a barrier to tumor growth, as critically short telomeres can trigger DNA repair pathways that prevent uncontrolled cell division [5][13].

In the context of aging, telomere shortening is associated with a decline in cellular function and an increase in age-related diseases. The average telomere length in somatic cells decreases with age, which is thought to contribute to the loss of (stem) cells and increase the likelihood of developing age-related disorders, including cancer [1][5]. Specifically, short telomeres have been implicated in various syndromes that exhibit premature aging and heightened cancer risk, such as dyskeratosis congenita and aplastic anemia [5].

Conversely, in cancer cells, telomerase, the enzyme responsible for elongating telomeres, is often reactivated. Approximately 90% of human cancers exhibit increased telomerase activity, which allows these cells to maintain their telomere length and continue dividing beyond the normal limits of cellular replication [7]. The reactivation of telomerase is often triggered by mutations and epigenetic changes, which enable cancer cells to evade the growth-limiting effects of short telomeres [14].

Moreover, the role of telomerase extends beyond mere telomere maintenance. It has been shown to influence other cellular pathways, including those involved in growth and inflammation, thereby promoting tumorigenesis [9]. This interplay between telomere length, telomerase activity, and cellular senescence highlights the dual role of telomeres in both aging and cancer: while they serve as a protective mechanism against tumorigenesis in healthy cells, their dysfunction and reactivation in cancer cells facilitate uncontrolled proliferation [1][10].

In summary, telomeres are integral to the aging process and cancer development. Their gradual shortening contributes to cellular aging and limits cell division, whereas the reactivation of telomerase in cancer cells allows for continued proliferation and tumor growth. Understanding these dynamics is essential for developing therapeutic strategies aimed at targeting telomerase in cancer treatment and potentially addressing age-related diseases [9][10].

5 Therapeutic Implications ​

5.1 Targeting Telomerase in Cancer Therapy ​

Telomeres are repetitive DNA sequences located at the ends of linear chromosomes, playing a crucial role in maintaining genomic stability and cellular lifespan. As cells divide, telomeres progressively shorten, which ultimately leads to replicative senescence and apoptosis when they reach a critical length. This shortening is a hallmark of cellular aging and is implicated in various age-related pathologies. In somatic cells, telomerase activity is typically absent, which contributes to telomere erosion over time. However, most cancer cells exhibit reactivated telomerase, allowing them to maintain telomere length and continue dividing indefinitely, thereby contributing to tumorigenesis[10][14][15].

The relationship between telomeres, aging, and cancer is complex. Dysfunctional telomeres can initiate cellular senescence, which serves as a barrier to cancer development. However, cancer cells often circumvent this barrier by reactivating telomerase, which allows for continuous proliferation. This reactivation is associated with mechanisms such as methylation of the telomerase reverse transcriptase (TERT) promoter and regulation by lactate dehydrogenase B (LDHB) in specific cancers like pancreatic cancer[14].

From a therapeutic standpoint, targeting telomerase presents a promising strategy for cancer treatment. Given that telomerase is expressed in over 90% of human tumors but is largely absent in normal somatic cells, it offers a selective target for anticancer therapies. Inhibiting telomerase activity can potentially halt the proliferation of cancer cells while sparing normal cells, thus minimizing side effects associated with traditional chemotherapeutics[7][16].

Several approaches have been developed to target telomerase in cancer therapy. These include direct inhibitors of the enzyme, agents that target telomere structure, and immunotherapies aimed at eliciting an immune response against telomerase-expressing cancer cells. For instance, telomerase-targeted vaccines and oncolytic viruses driven by telomerase promoters are being explored as potential therapeutic interventions[17][18].

Moreover, understanding the dual role of telomerase in aging and cancer is critical for developing effective therapies. While inhibiting telomerase may prevent cancer cell proliferation, it could also have implications for normal cells, particularly in the context of aging and tissue regeneration. Therefore, the challenge lies in distinguishing between the therapeutic effects on cancer cells and the potential adverse effects on normal cells that rely on telomerase for maintaining their proliferative capacity[19][20].

In conclusion, telomeres play a pivotal role in both aging and cancer, with telomerase acting as a key regulator in these processes. Targeting telomerase presents a viable therapeutic avenue in cancer treatment, with ongoing research aimed at refining these strategies to enhance their efficacy and safety[21][22].

5.2 Potential Interventions to Preserve Telomere Length ​

Telomeres, the protective caps at the ends of chromosomes, play a crucial role in both aging and cancer, influencing cellular senescence, genomic stability, and tumorigenesis. Their maintenance is vital for cellular health, and their dysfunction is implicated in age-related diseases and cancer progression.

As cells divide, telomeres shorten, which eventually leads to cellular senescence or apoptosis. This process serves as a natural barrier against tumorigenesis. In somatic cells, the lack of telomerase activity results in progressive telomere shortening, correlating with age-related pathologies. Specifically, the absence of telomerase activity in human somatic tissues leads to telomere erosion, which is associated with various age-related disorders, including cancer (Geserick and Blasco, 2006; Aubert and Lansdorp, 2008).

Interestingly, while short telomeres can limit tumor growth by triggering DNA repair mechanisms and cellular senescence, cancer cells often reactivate telomerase to maintain telomere length, allowing them to bypass these growth-limiting effects. This dual role of telomerase complicates its relationship with cancer; while its activation is necessary for tumor survival, it can also promote oncogenic changes within chromosomes, thus sustaining tumorigenesis (Boccardi and Marano, 2024; Ait-Aissa et al., 2016).

The therapeutic implications of these findings are significant. Strategies aimed at preserving telomere length or modulating telomerase activity could potentially extend cellular lifespan and combat aging. Telomerase activation has been suggested as a method to enhance cellular longevity and tissue regeneration, while telomerase inhibition emerges as a promising therapeutic approach for cancer (Jafri et al., 2016; Razgonova et al., 2020). The development of telomerase inhibitors has been explored as a cancer treatment strategy, given that telomerase is expressed in over 90% of human cancers (Ahmed and Tollefsbol, 2003; Blasco, 2005).

Potential interventions to preserve telomere length include lifestyle modifications, such as diet and exercise, which have been shown to positively influence telomere dynamics. Additionally, pharmacological agents targeting telomerase or telomere maintenance mechanisms are under investigation. For instance, telomerase inhibitors like Imetelstat are being evaluated in clinical trials, aiming to selectively target telomerase-expressing cancer cells (Ouellette et al., 2011; Berei et al., 2020).

Moreover, understanding the regulatory mechanisms governing telomere dynamics, including the influence of environmental factors and genetic variations, is crucial for developing effective therapeutic strategies. The ongoing research in this field seeks to unravel the complexities of telomere biology and its implications for aging and cancer, ultimately guiding the development of targeted interventions to enhance healthspan and mitigate cancer risk (Lv et al., 2024; Kim et al., 2002).

In conclusion, telomeres serve as critical determinants of cellular aging and cancer susceptibility. Their maintenance is not only vital for genome stability but also represents a promising target for therapeutic interventions aimed at prolonging healthspan and treating age-related diseases and cancer. The future of telomere-focused therapies lies in harnessing their dual role in aging and cancer, balancing the need for cellular longevity with the prevention of tumorigenesis.

6 Future Directions in Telomere Research ​

6.1 Emerging Technologies in Telomere Studies ​

Telomeres, the protective caps located at the ends of linear chromosomes, play a pivotal role in the processes of aging and cancer. They are composed of repetitive DNA sequences and associated proteins that maintain genomic integrity and stability. As cells divide, telomeres gradually shorten, which eventually leads to replicative senescence or apoptosis when they reach a critical length. This process is significant in aging, as the progressive loss of telomere length is associated with age-related pathologies, including various cancers.

In the context of aging, telomeres serve as a biological clock for cells. The gradual shortening of telomeres is a hallmark of cellular aging, where insufficient telomere length can trigger DNA repair pathways and cellular senescence, thus limiting the proliferative capacity of somatic cells (Aubert & Lansdorp, 2008). This telomere attrition is compounded by factors such as oxidative stress and inflammation, which can further accelerate telomere shortening (Boccardi & Marano, 2024). Conversely, excessively long telomeres can also be problematic, as they have been linked to increased cancer risk. The delicate balance of telomere length is crucial for maintaining cellular homeostasis and preventing oncogenic transformations (Boccardi & Marano, 2025).

In cancer, the role of telomeres is paradoxical. While short telomeres can inhibit tumor growth by triggering senescence, many cancer cells reactivate telomerase, the enzyme responsible for elongating telomeres, allowing them to bypass these growth-limiting effects (Shen et al., 2023). This reactivation of telomerase is observed in over 90% of human cancers, facilitating the continuous division of cancer cells and contributing to tumorigenesis (Ahmed & Tollefsbol, 2003). Furthermore, telomere dysfunction is associated with chromosomal instability, which can drive the progression of cancer by promoting genetic diversity and adaptability in tumor cells (Kim et al., 2002).

Emerging technologies in telomere research are focused on understanding the molecular mechanisms governing telomere dynamics and their implications in aging and cancer. Advances in genomics and bioinformatics are enabling researchers to explore telomere length variations across different populations and their association with disease susceptibility. High-throughput sequencing techniques allow for the precise measurement of telomere length and structure, providing insights into the role of telomeres in cellular senescence and cancer development (Ouellette et al., 2011).

Additionally, the development of small-molecule drugs targeting telomerase represents a promising therapeutic strategy in oncology. These drugs aim to inhibit telomerase activity in cancer cells, potentially leading to tumor regression and improved patient outcomes (Berei et al., 2020). Furthermore, understanding the non-canonical functions of telomerase beyond telomere maintenance, such as its involvement in cell signaling pathways and metabolic regulation, may uncover new therapeutic targets (Ait-Aissa et al., 2016).

In summary, telomeres are integral to the biology of aging and cancer, with their length and stability influencing cellular lifespan and tumorigenesis. Future research utilizing advanced technologies is essential for unraveling the complex interplay between telomeres, aging, and cancer, paving the way for novel therapeutic interventions aimed at promoting healthy aging and effective cancer treatments.

6.2 The Role of Telomeres in Personalized Medicine ​

Telomeres, the protective caps located at the ends of chromosomes, play a critical role in the processes of aging and cancer. They are composed of repetitive DNA sequences and associated proteins, which function to maintain genomic stability and integrity. As cells divide, telomeres progressively shorten due to the end-replication problem, leading to replicative senescence or apoptosis when they reach a critically short length. This mechanism acts as a barrier to tumorigenesis, as it limits the number of times a cell can divide, thereby reducing the risk of accumulating oncogenic mutations (Aubert and Lansdorp, 2008; Boccardi and Marano, 2025).

In the context of aging, telomere shortening is associated with various age-related diseases, including cancer. The average telomere length decreases with age, and critically short or "uncapped" telomeres can trigger cellular senescence or apoptosis, contributing to the decline in tissue regeneration and function observed in older individuals (Geserick and Blasco, 2006). Moreover, individuals with short telomeres are at an increased risk for disorders such as dyskeratosis congenita, aplastic anemia, and certain cancers (Aubert and Lansdorp, 2008).

Conversely, in cancer cells, telomerase—a ribonucleoprotein enzyme responsible for elongating telomeres—is often reactivated, allowing these cells to bypass the growth-limiting effects of telomere shortening. This reactivation enables cancer cells to divide indefinitely, promoting tumor growth and progression (Ahmed and Tollefsbol, 2003; Armanios, 2022). Interestingly, while short telomeres have been traditionally viewed as drivers of genomic instability leading to cancer, recent findings suggest that long telomeres may also be a significant risk factor for certain cancers, as they can promote cellular immortality and tumorigenesis through different mechanisms (Boccardi and Marano, 2024).

The intricate relationship between telomeres, aging, and cancer has significant implications for personalized medicine. Understanding individual variations in telomere length and telomerase activity can aid in the development of tailored therapeutic strategies. For instance, telomerase inhibitors are being explored as potential cancer treatments, aiming to selectively target cancer cells while sparing normal somatic cells that typically exhibit low telomerase activity (Ouellette et al., 2011). Furthermore, telomere length assessment may serve as a biomarker for predicting cancer risk and informing treatment decisions (Lansdorp, 2022).

Future research directions in telomere biology should focus on elucidating the non-canonical functions of telomerase beyond telomere maintenance, exploring its role in various cellular signaling pathways and its impact on aging and cancer (Ait-Aissa et al., 2016). Additionally, large longitudinal studies are essential to further understand the dynamics of telomere length in relation to aging and cancer susceptibility, which is crucial for the development of effective interventions aimed at promoting healthy aging and mitigating cancer risk (Boccardi and Marano, 2025).

In summary, telomeres serve as critical regulators of cellular aging and cancer progression. Their dual role in limiting cell division and promoting cellular immortality underscores the complexity of their functions in human health and disease, paving the way for innovative approaches in personalized medicine targeting telomere biology.

7 Conclusion ​

The interplay between telomeres, aging, and cancer presents a complex yet fascinating area of research that holds significant implications for understanding fundamental biological processes. Key findings indicate that telomeres serve as critical regulators of cellular lifespan, with their gradual shortening being a hallmark of aging and a barrier to tumorigenesis. However, the reactivation of telomerase in cancer cells enables them to bypass this barrier, facilitating continuous proliferation and contributing to genomic instability. This dual role underscores the necessity for maintaining telomere homeostasis, which could be pivotal in promoting healthy aging and reducing cancer risk. Current therapeutic strategies targeting telomerase are promising, yet they must balance efficacy in cancer treatment with the potential impact on normal cellular functions. Future research directions should focus on unraveling the molecular mechanisms governing telomere dynamics, exploring the role of telomeres in personalized medicine, and developing innovative interventions aimed at both enhancing healthspan and mitigating cancer susceptibility. As our understanding of telomere biology advances, it may pave the way for novel therapeutic approaches that could significantly improve health outcomes in aging populations and cancer patients alike.

References ​

  • [1] Virginia Boccardi;Luigi Marano. The telomere connection between aging and cancer: The burden of replication stress and dysfunction.. Mechanisms of ageing and development(IF=5.1). 2025. PMID:39805504. DOI: 10.1016/j.mad.2025.112026.
  • [2] V Urquidi;D Tarin;S Goodison. Telomerase in cancer: clinical applications.. Annals of medicine(IF=4.3). 1998. PMID:9814828. DOI: 10.3109/07853899809002483.
  • [3] Peter M Lansdorp. Telomeres, stem cells, and hematology.. Blood(IF=23.1). 2008. PMID:18263784. DOI: 10.1182/blood-2007-09-084913.
  • [4] Peter M Lansdorp. Telomeres, Telomerase and Cancer.. Archives of medical research(IF=3.4). 2022. PMID:36334946. DOI: 10.1016/j.arcmed.2022.10.004.
  • [5] Geraldine Aubert;Peter M Lansdorp. Telomeres and aging.. Physiological reviews(IF=28.7). 2008. PMID:18391173. DOI: 10.1152/physrev.00026.2007.
  • [6] Christoph Geserick;Maria A Blasco. Novel roles for telomerase in aging.. Mechanisms of ageing and development(IF=5.1). 2006. PMID:16516269. DOI: 10.1016/j.mad.2006.01.017.
  • [7] Ali Ahmed;Trygve Tollefsbol. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.. Journal of the American Geriatrics Society(IF=4.5). 2003. PMID:12534855. DOI: 10.1034/j.1601-5215.2002.51019.x.
  • [8] Vera Gorbunova;Andrei Seluanov. Coevolution of telomerase activity and body mass in mammals: from mice to beavers.. Mechanisms of ageing and development(IF=5.1). 2009. PMID:18387652. DOI: 10.1016/j.mad.2008.02.008.
  • [9] Virginia Boccardi;Luigi Marano. Aging, Cancer, and Inflammation: The Telomerase Connection.. International journal of molecular sciences(IF=4.9). 2024. PMID:39126110. DOI: 10.3390/ijms25158542.
  • [10] Ziyi Shen;Yuanhui Wang;Guanzhen Wang;Wei Gu;Shengchao Zhao;Xiaomeng Hu;Wei Liu;Yi Cai;Zhihong Ma;Rupesh K Gautam;Jia Jia;Chunpeng Craig Wan;Tingdong Yan. Research progress of small-molecule drugs in targeting telomerase in human cancer and aging.. Chemico-biological interactions(IF=5.4). 2023. PMID:37451664. DOI: 10.1016/j.cbi.2023.110631.
  • [11] Mary Armanios. The Role of Telomeres in Human Disease.. Annual review of genomics and human genetics(IF=7.9). 2022. PMID:35609925. DOI: 10.1146/annurev-genom-010422-091101.
  • [12] Sahn-ho Kim Sh;Patrick Kaminker;Judith Campisi. Telomeres, aging and cancer: in search of a happy ending.. Oncogene(IF=7.3). 2002. PMID:11850775. DOI: 10.1038/sj.onc.1205077.
  • [13] Peter M Lansdorp. Telomeres, aging, and cancer: the big picture.. Blood(IF=23.1). 2022. PMID:35142846. DOI: 10.1182/blood.2021014299.
  • [14] Songting Shou;Yuanliang Li;Jiaqin Chen;Xing Zhang;Chuanlong Zhang;Xiaochen Jiang;Fudong Liu;Li Yi;Xiyuan Zhang;En Geer;Zhenqing Pu;Bo Pang. Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.. Cancer gene therapy(IF=5.0). 2024. PMID:38594465. DOI: 10.1038/s41417-024-00768-6.
  • [15] Michel M Ouellette;Woodring E Wright;Jerry W Shay. Targeting telomerase-expressing cancer cells.. Journal of cellular and molecular medicine(IF=4.2). 2011. PMID:21332640. DOI: 10.1111/j.1582-4934.2011.01279.x.
  • [16] P Phatak;A M Burger. Telomerase and its potential for therapeutic intervention.. British journal of pharmacology(IF=7.7). 2007. PMID:17603541. DOI: 10.1038/sj.bjp.0707374.
  • [17] Eishiro Mizukoshi;Shuichi Kaneko. Telomerase-Targeted Cancer Immunotherapy.. International journal of molecular sciences(IF=4.9). 2019. PMID:31013796. DOI: 10.3390/ijms20081823.
  • [18] Songting Shou;Ayidana Maolan;Di Zhang;Xiaochen Jiang;Fudong Liu;Yi Li;Xiyuan Zhang;En Geer;Zhenqing Pu;Baojin Hua;Qiujun Guo;Xing Zhang;Bo Pang. Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.. Experimental hematology & oncology(IF=13.5). 2025. PMID:39871386. DOI: 10.1186/s40164-025-00597-9.
  • [19] Bruno Bernardes de Jesus;Maria A Blasco. Telomerase at the intersection of cancer and aging.. Trends in genetics : TIG(IF=16.3). 2013. PMID:23876621. DOI: .
  • [20] Mert Burak Ozturk;Yinghui Li;Vinay Tergaonkar. Current Insights to Regulation and Role of Telomerase in Human Diseases.. Antioxidants (Basel, Switzerland)(IF=6.6). 2017. PMID:28264499. DOI: 10.3390/antiox6010017.
  • [21] R Dahse;W Fiedler;G Ernst. Telomeres and telomerase: biological and clinical importance.. Clinical chemistry(IF=6.3). 1997. PMID:9166220. DOI: .
  • [22] Kenkichi Masutomi;William C Hahn. Telomerase and tumorigenesis.. Cancer letters(IF=10.1). 2003. PMID:12757974. DOI: 10.1016/s0304-3835(02)00703-6.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Telomeres · Aging · Cancer · Cellular Senescence · Telomerase

© 2025 MaltSci